V.TLT
|
Agree'd...My guess is Feb. 28 after hours...or early March 1.
|
V.TLT
|
Agree'd....My continued interest and investment in Theralase over these 8...
|
V.TLT
|
Wishing all contributors to this board a blessed 2022. As I enter my 8th...
|
V.TLT
|
What, in God's name, could Dr, Mc Farland/ Team have discovered that...
|
V.TLT
|
Inexplicable!...Wow!!!
|
V.TLT
|
You've been a community member since November, 21, 2021. Thanks for the...
|
V.TLT
|
My Word!...Well done!!...Let us hope that your calculations are the beginning...
|
V.TLT
|
Perfectly articulated...thank you.
|
V.TLT
|
From the UChicagoMedicine Trial Site: This is a Phase II, open label, single...
|
V.TLT
|
Yes, Enriquesuave, the data and prospects for the company have continued to...
|
V.TLT
|
Perhaps the company’s equity price is indicative of a dilemma that long term...
|
V.TLT
|
It remains, for me, a testament to the brilliance of this company’s clinical...
|
V.TLT
|
Could there be a potential buy out of the company’s clinical division? Thus...
|
V.TLT
|
Thanks, StevenBirch....The longer this wait extends the less I am inclined to...
|
V.TLT
|
Could the company have acquired enough positive clinical data by the end of...
|
V.TLT
|
Interesting point, Cashascars...It has crossed my mind that, perhaps, the...
|
V.TLT
|
Hi Jaro 1977...Despite my multiple attempts to forward you the link to the...
|
V.TLT
|
On an alternative discussion board a poster recently suggested that, at the...
|
V.TLT
|
“Take note of the following...” Thanks, Pandora!
|
V.TLT
|
You and me both, Fred!...LOL...And I am sure many others.
|